Back to search

United Kingdom· GB-APID-38653811000001106

Ajovy 225mg/1.5ml solution for injection pre-filled pens

A fremanezumab product containing fremanezumab, registered in United Kingdom by Teva UK Ltd. The same ATC class is registered in 15 of our 19 countries.

ATC N02CD03

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedAjovy 225mg/1.5ml solution for inject…ATCN02CD03REGISTER NO.GB-APID-3865381100000…PACKS LISTED3CHECKEDSeptember 13, 2026

Where it is registered

Fremanezumab is registered in 15 of 19 countries.

Countries holding a registration under ATC N02CD03 (fremanezumab), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 10 of them publish a price we can compare per daily dose

Fremanezumab · ATC N02CD03

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Fremanezumab
Manufacturer
Teva UK Ltd
Country
United Kingdom (GB)
ATC code
N02CD03
ATC class
Fremanezumab
Defined daily dose
7.5 mg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 3

  • gtin
    5017007601951
  • gtin
    5017007603924
  • gtin
    5017007603931

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fremanezumab in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fremanezumab products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Ajovy
  • Liechtenstein · Ajovy
  • Norway · Ajovy

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/97f10bba-ff04-4fe4-833e-73037a46e8f4
GET /v1/drugs/97f10bba-ff04-4fe4-833e-73037a46e8f4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "38653811000001106",
  "desc": "Ajovy 225mg/1.5ml solution for injection pre-filled pens (Teva UK Ltd)",
  "form": "Solution for injection",
  "vpid": "38658911000001106",
  "source": "dmd",
  "vtm_id": "781151005",
  "strength": "150 mg",
  "substance": "Fremanezumab",
  "ingredient": "Fremanezumab",
  "supplier_code": "3849901000001105"
}

See everything about fremanezumab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.